177 related articles for article (PubMed ID: 31227667)
1. Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study.
Shoval H; Levin J; Friel K; Kim H
J Pediatr Rehabil Med; 2019; 12(2):189-196. PubMed ID: 31227667
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
3. Cumulative Efficacy of Longitudinal Repeat Salivary Gland OnabotulinumtoxinA Injection: A Retrospective Study.
Shoval H; Friel K; Levin J; Kim H
Am J Phys Med Rehabil; 2021 Aug; 100(8):798-802. PubMed ID: 33394592
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
5. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
Dohar JE
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
[TBL] [Abstract][Full Text] [Related]
6. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands.
Jongerius PH; Joosten F; Hoogen FJ; Gabreels FJ; Rotteveel JJ
Laryngoscope; 2003 Jan; 113(1):107-11. PubMed ID: 12514392
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
8. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.
Berweck S; Schroeder AS; Lee SH; Bigalke H; Heinen F
Dev Med Child Neurol; 2007 Jan; 49(1):62-4. PubMed ID: 17209979
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.
Wang YJ; Gao BQ
World J Pediatr; 2013 Nov; 9(4):342-5. PubMed ID: 24235067
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for children with salivary control problems.
Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
[TBL] [Abstract][Full Text] [Related]
11. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Chowdhury NA; Sewatsky ML; Kim H
Am J Phys Med Rehabil; 2017 Aug; 96(8):e151-e154. PubMed ID: 28081025
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sialorrhea with botulinum toxin injections in pediatric patients less than three years of age.
Fan T; Frederick R; Abualsoud A; Sheyn A; McLevy-Bazzanella J; Thompson J; Akkus C; Wood J
Int J Pediatr Otorhinolaryngol; 2022 Jul; 158():111185. PubMed ID: 35594794
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
14. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.
Lin YC; Shieh JY; Cheng ML; Yang PY
Neurology; 2008 Jan; 70(4):316-8. PubMed ID: 18209205
[No Abstract] [Full Text] [Related]
16. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
18. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
19. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
20. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
